Calamos Advisors LLC Takes Position in Amedisys, Inc. (NASDAQ:AMED)

Calamos Advisors LLC purchased a new stake in Amedisys, Inc. (NASDAQ:AMED) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 242,110 shares of the health services provider’s stock, valued at approximately $23,015,000.

Several other large investors have also added to or reduced their stakes in AMED. Raymond James & Associates boosted its holdings in Amedisys by 6.5% during the first quarter. Raymond James & Associates now owns 11,101 shares of the health services provider’s stock worth $1,913,000 after purchasing an additional 680 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its holdings in Amedisys by 9.2% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 2,397 shares of the health services provider’s stock worth $413,000 after purchasing an additional 202 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in Amedisys by 22.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 3,425 shares of the health services provider’s stock worth $590,000 after purchasing an additional 620 shares during the last quarter. HighTower Advisors LLC boosted its holdings in Amedisys by 40.4% during the first quarter. HighTower Advisors LLC now owns 7,619 shares of the health services provider’s stock worth $1,310,000 after purchasing an additional 2,193 shares during the last quarter. Finally, Citigroup Inc. lifted its stake in Amedisys by 6.4% in the first quarter. Citigroup Inc. now owns 13,268 shares of the health services provider’s stock valued at $2,287,000 after acquiring an additional 803 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Price Performance

Shares of AMED stock traded down $0.02 during midday trading on Friday, hitting $90.76. 8,779 shares of the company were exchanged, compared to its average volume of 279,837. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.05 and a current ratio of 1.05. The firm’s 50 day moving average price is $92.84 and its two-hundred day moving average price is $93.43. Amedisys, Inc. has a 52 week low of $73.10 and a 52 week high of $96.44.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, February 21st. The health services provider reported $0.94 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.10). The business had revenue of $570.79 million during the quarter, compared to the consensus estimate of $566.85 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.16 EPS. As a group, equities analysts forecast that Amedisys, Inc. will post 4.54 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AMED has been the topic of several recent analyst reports. Royal Bank of Canada boosted their price objective on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. Raymond James restated a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Finally, StockNews.com initiated coverage on shares of Amedisys in a research note on Monday, April 8th. They set a “buy” rating on the stock. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Amedisys has an average rating of “Hold” and a consensus target price of $97.50.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.